Cingulate (CING) vs Heron Therapeutics (HRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cingulate (CING) has outperformed Heron Therapeutics (HRTX) over the past year, gaining 17.3% versus a loss of 70.9%. Cingulate is the larger company by market cap ($71.2 million vs $70.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CING | HRTX |
|---|---|---|
| Share price | $4.90 | $0.3719 |
| Market cap | $71.18M | $70.61M |
| 1-day change | +0.51% | -3.23% |
| YTD return | +12.21% | -70.44% |
| 1-year return | +17.35% | -70.89% |
| 5-year return | — | -96.37% |
| EPS (TTM) | $-3.51 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.89 | $1.58 |
| 52-week low | $3.16 | $0.26 |
| Distance from 52-week high | -58.83% | -76.46% |
| Average volume | 139.16K | 2.58M |
| Shares outstanding | 14.54M | 189.85M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CING has outperformed HRTX by 88.2 percentage points over the past year.
CING vs HRTX FAQ
Which is bigger, Cingulate or Heron Therapeutics?
Cingulate (CING) is larger, with a market capitalization of $71.18M compared with $70.61M for Heron Therapeutics (HRTX).
Which stock has performed better over the past year, CING or HRTX?
CING returned +17.35% over the past 12 months, compared with -70.89% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Are Cingulate and Heron Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.